Biora Therapeutics Stock (NASDAQ: BIOR) stock price, news, charts, stock research, profile.
Open | $0.62 |
Close | $0.63 |
Volume / Avg. | 160.33K / 294.88K |
Day Range | 0.62 - 0.65 |
52 Wk Range | 0.48 - 4.22 |
Market Cap | $22.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 8.48% |
Days to Cover | 6.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biora Therapeutics (NASDAQ:BIOR) through any online brokerage.
Other companies in Biora Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Viracta Therapeutics (NASDAQ:VIRX) and Indaptus Therapeutics (NASDAQ:INDP).
There is no analysis for Biora Therapeutics.
Biora Therapeutics has a consensus price target of $15.00.
The stock price for Biora Therapeutics (NASDAQ: BIOR) is $0.6297 last updated Today at July 3, 2024 at 3:52 PM EDT.
There are no upcoming dividends for Biora Therapeutics.
Biora Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Biora Therapeutics.
Biora Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.